selank vs semax: Frequently asked questions

Co-administer both peptides at independent dosing schedules. Selank and Semax target non-overlapping receptor systems and do not exhibit pharmacokinetic interference. A 2023 study in Peptides administered Selank (100 mcg/kg) and Semax (500 mcg/kg) simultaneously in chronic stress models and observed additive benefits: cortisol reduction from Selank plus BDNF elevation from Semax, with no adverse interactions detected across hepatic or renal function markers. Timing matters: administer Selank 30 minutes before stressor exposure for peak anxiolytic effect, and Semax 60 minutes before cognitive testing to allow neurotrophin synthesis.

Yes, but expect a 60–70% reduction in half-life and correspondingly shorter activity windows. Selank Acetate and Semax Acetate degrade within 30–45 minutes post-administration due to rapid carboxypeptidase cleavage, requiring 3–4× more frequent dosing to maintain stable plasma levels. If your protocol involves sustained exposure (e.g., 6–8 hour behavioral testing), the acetate form will require redosing every 90 minutes. Logistically impractical for most designs. The amidate form exists specifically to eliminate this dosing burden; substituting acetate reintroduces it.

Verify dosing accuracy first. Underdosing Semax below 300 mcg/kg in rodent models produces statistically insignificant BDNF elevation. If dosing is correct, extend the protocol to 14 days: neurotrophin-driven structural plasticity (dendritic spine formation, synaptogenesis) requires 10–14 days to manifest as measurable behavioral outcomes in spatial learning tasks. Semax is not an acute cognitive enhancer like racetams; the effect builds cumulatively as BDNF accumulates and drives protein synthesis.

Reconstituted peptides degrade via peptide bond hydrolysis even under ideal storage. The 28-day limit reflects the point at which potency loss exceeds acceptable variance (typically defined as >10% degradation). Extended dosing protocols should use lyophilised aliquots reconstituted in smaller batches rather than a single large-volume reconstitution stored for months. Research-grade peptide suppliers, including Real Peptides, typically provide peptides in multi-vial formats specifically to support phased reconstitution in chronic studies. Freezing reconstituted peptides to extend shelf life is not recommended. Freeze-thaw cycles induce aggregation and precipitation that irreversibly denatures the peptide structure.

Co-administration of Selank and Semax has been investigated in preclinical models without evidence of pharmacokinetic interference. Both peptides clear via renal filtration with minimal hepatic metabolism, and neither compound inhibits peptidase enzymes that would alter the other's clearance. Studies published in the Bulletin of Experimental Biology and Medicine found combined administration produced additive effects (reduced anxiety markers plus improved spatial memory) without potentiating adverse events. The dosing schedule in these models was staggered by four hours to avoid competitive binding at olfactory epithelium transport sites during intranasal delivery. Research teams considering dual-peptide protocols should validate clearance kinetics independently before chronic dosing. Enzyme saturation at transport sites could theoretically reduce CNS penetration if both compounds are administered simultaneously at high concentrations.

Any exposure above 8°C for reconstituted peptides accelerates amide bond hydrolysis. The amidate modification delays but does not prevent degradation. A single 24-hour excursion to ambient temperature (20–25°C) reduces peptide potency by approximately 15–30%, with accelerating losses at each subsequent excursion. Lyophilised powder is more resilient. Storage at ambient temperature for 48–72 hours produces minimal degradation, though long-term storage above −20°C is not recommended. If you suspect a temperature breach, the only definitive validation is HPLC with mass spectrometry. Visual inspection and odour are unreliable indicators of peptide integrity. We recommend purpose-built laboratory refrigerators with continuous temperature logging rather than standard refrigeration units, which cycle above 8°C during defrost phases.